Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

A predictive control algorithm operated via an Android smartphone which acts as an artificial pancreas system has proven ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old and above. Tidepool, an open-source diabetes non-profit founded in 2013 and driving ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

A Pittsburgh firm is harnessing artificial intelligence to make it easier for military aircraft to land on ships at sea.

A Victorian mum who was patient zero in a world-first trial that used an app to act as her artificial pancreas has spoken of ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Developments in health technology allow us to take more personal responsibility for our wellbeing, which may have significant ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Los Angeles-based Cedars-Sinai is refining its approach to inpatient diabetes management by integrating standardized protocols, technology and multidisciplinary teams aimed at reducing complications ...

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ ...